Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kelly A. Wong
Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients
Journal of Immunology Research
Medicine
Allergy
Immunology
Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Gastroenterology
Hepatology
Gastroenterology
Hepatitis C Virus Resistance to Antiviral Therapy
Hepatology
Medicine
Hepatology
Prevalence of Resistance-Associated Substitutions to Direct-Acting Antiviral Agents in Hemodialysis and Renal Transplant Patients Infected With Hepatitis C Virus
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Detection of Hepatitis C Virus-Rna in Saliva From Chronically HCV-Infected Patients
International Journal of Immunopathology and Pharmacology
Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor
Journal of Clinical Microbiology
Microbiology
